Literature DB >> 28674899

High-Throughput Parallel Proteomic Sample Preparation Using 96-Well Polyvinylidene Fluoride (PVDF) Membranes and C18 Purification Plates.

Tue Bjerg Bennike1, Hanno Steen2.   

Abstract

Meaningful proteomic-based biomarker discovery projects using primary human-derived specimens require the analysis of hundreds of samples in order to address the issue of interpersonal variability. Thus, robust high-throughput methods for the digestion of plasma samples are a prerequisite for such large clinical proteomic studies with hundreds of samples. Commonly used sample preparation methods are often difficult to parallelize and/or automate. Herein we describe a method for parallel 96-well plate-based sample preparation. Protein digestion is performed in 96-well polyvinylidene fluoride (PVDF) membrane plates and the subsequent purification in 96-well reversed phase C18 purification plates, enabling the usage of multichannel pipettes in all steps. The protocol can be applied using neat or depleted plasma/serum samples, but has also proven effective with other sample types.

Entities:  

Keywords:  Automatization; Depleted; Method; Multichannel pipette; Plasma; Protein digestion; Sample processing; Serum

Mesh:

Substances:

Year:  2017        PMID: 28674899     DOI: 10.1007/978-1-4939-7057-5_27

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  7 in total

1.  Using plasma proteomics to investigate viral infections of the central nervous system including patients with HIV-associated neurocognitive disorders.

Authors:  Saima Ahmed; Arthur Viode; Patrick van Zalm; Judith Steen; Shibani S Mukerji; Hanno Steen
Journal:  J Neurovirol       Date:  2022-05-31       Impact factor: 3.739

2.  Immunophenotyping assessment in a COVID-19 cohort (IMPACC): A prospective longitudinal study.

Authors: 
Journal:  Sci Immunol       Date:  2021-08-10

3.  A Cost-Effective High-Throughput Plasma and Serum Proteomics Workflow Enables Mapping of the Molecular Impact of Total Pancreatectomy with Islet Autotransplantation.

Authors:  Tue Bjerg Bennike; Melena D Bellin; Yue Xuan; Allan Stensballe; Frederik Trier Møller; Gregory J Beilman; Ofer Levy; Zobeida Cruz-Monserrate; Vibeke Andersen; Judith Steen; Darwin L Conwell; Hanno Steen
Journal:  J Proteome Res       Date:  2018-04-19       Impact factor: 4.466

4.  Determinants of B-Cell Compartment Hyperactivation in European Adolescents Living With Perinatally Acquired HIV-1 After Over 10 Years of Suppressive Therapy.

Authors:  Alessandra Ruggiero; Giuseppe Rubens Pascucci; Nicola Cotugno; Sara Domínguez-Rodríguez; Stefano Rinaldi; Alfredo Tagarro; Pablo Rojo; Caroline Foster; Alasdair Bamford; Anita De Rossi; Eleni Nastouli; Nigel Klein; Elena Morrocchi; Benoit Fatou; Kinga K Smolen; Al Ozonoff; Michela Di Pastena; Katherine Luzuriaga; Hanno Steen; Carlo Giaquinto; Philip Goulder; Paolo Rossi; Ofer Levy; Savita Pahwa; Paolo Palma
Journal:  Front Immunol       Date:  2022-03-31       Impact factor: 7.561

Review 5.  First International Precision Vaccines Conference: Multidisciplinary Approaches to Next-Generation Vaccines.

Authors:  Francesco Borriello; Simon D van Haren; Ofer Levy
Journal:  mSphere       Date:  2018-08-01       Impact factor: 4.389

6.  Preparing for Life: Plasma Proteome Changes and Immune System Development During the First Week of Human Life.

Authors:  Tue Bjerg Bennike; Benoit Fatou; Asimenia Angelidou; Joann Diray-Arce; Reza Falsafi; Rebecca Ford; Erin E Gill; Simon D van Haren; Olubukola T Idoko; Amy H Lee; Rym Ben-Othman; William S Pomat; Casey P Shannon; Kinga K Smolen; Scott J Tebbutt; Al Ozonoff; Peter C Richmond; Anita H J van den Biggelaar; Robert E W Hancock; Beate Kampmann; Tobias R Kollmann; Ofer Levy; Hanno Steen
Journal:  Front Immunol       Date:  2020-10-20       Impact factor: 7.561

7.  Plasma Proteomic Analysis Distinguishes Severity Outcomes of Human Ebola Virus Disease.

Authors:  Arthur Viodé; Kinga K Smolen; Eleanor N Fish; Hanno Steen; Benoit Fatou; Zainab Wurie; Patrick Van Zalm; Mandy Kader Konde; Balla Moussa Keita; Richard Amento Ablam
Journal:  mBio       Date:  2022-04-21       Impact factor: 7.786

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.